FBRX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata...

Stats
Today's Volume	9 056.00
Average Volume	24 596.00
Market Cap	21.64M
EPS	$0 ( 2024-05-20 )
Next earnings date	( $-0.160 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.710
ATR14	$0.00700 (1.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Riley Antony A	Buy	9 375	Common Stock
2024-04-01	Riley Antony A	Sell	3 345	Common Stock
2024-04-01	Riley Antony A	Sell	9 375	Restricted Stock Units
2024-04-01	Wagner Paul A.	Buy	31 250	Common Stock
2024-04-01	Wagner Paul A.	Sell	2 453	Common Stock

INSIDER POWER
86.93
Last 94 transactions
Buy: 4 603 379 \| Sell: 363 400

Volume Correlation

Long: 0.00 (neutral)

Short: -0.82 (strong negative)

Signal:(50.228) Neutral

Forte Biosciences, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Forte Biosciences, Inc. Correlation - Currency/Commodity

0.20
( neutral )

0.03
( neutral )

0.00
( neutral )

0.04
( neutral )

-0.12
( neutral )

Forte Biosciences, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-9 000.00 (0.00 %)
EPS:	$-1.000

FY	2023
Revenue:	$0
Gross Profit:	$-9 000.00 (0.00 %)
EPS:	$-1.000

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.800

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.550

Financial Reports:

No articles found.

Forte Biosciences, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Forte Biosciences, Inc.